The decrease in paclitaxel CL noticed while in the presence of zosuquidar led to a boost in time that the plasma paclitaxel focus stays over 0.one mol L−1, which is known for being a marker of each toxicity (neutropenia) and efficacy [one]. Although the effect of zosuquidar over the toxicity https://elagabalusc332pal5.blogdomago.com/profile